December 21, 2012
At a meeting on December 19, the Pharmaceutical Affairs Council (PAC) of the Pharmaceutical Affairs and Food Sanitation Council (PAFSC) recommended approval for the OTC Switching of the hyperlipidemia treatment Epadel (ethyl icosapentate) as recommended earlier at the PAFSC’s Committee...read more